Longer-form thinking on where the market goes.
17 white papers
NAIOP Research Foundation report evaluating risks and opportunities in office building conversions to life science, medical, and multifamily uses, based on market data review and developer interviews.
Expert commentary on co-locating life sciences and technology sectors in Denver real estate to drive regional innovation.
Knight Frank examines the capital requirements and investment dynamics supporting UK life sciences innovation beyond real estate considerations.
At the 2026 ULI Carolinas Meeting, leaders from government, life sciences, and professional sports argued that housing, infrastructure, and energy systems—not population growth itself—will determine whether the region can sustain its momentum.
Technology labs are becoming critical assets requiring specialized CRE strategies and operational expertise
Technology labs are becoming critical assets requiring specialized CRE strategies and operational expertise
The life science industry has climbed out of one of the most complicated stretches in its history, and while the underlying business is healthier than it has been in years, the region’s glut of high-quality but unbuilt lab space remains stubbornly locked up. The life science sector has weathered “one of its most…
Exploration of how the 5th Industrial Revolution and AI adoption are reshaping real estate strategies and asset positioning.
This is a viewpoint-commentary published by Institutional Real Estate, Inc. in April 2026 addressing how demand in Asia Pacific life sciences and research and development real estate can be converted into investment opportunities. The piece covers topics related to capital markets and economic considerations in this property sector.
Analysis of office-to-alternate-use conversion trends, arguing that life sciences properties experienced greater market impact than multifamily adaptive reuse projects.
While pharmaceutical companies acquire sponsor-backed biotech companies, corporate real estate teams are becoming more responsible for preserving the value of those deals, according to a new CBRE insight. Even as acquired biotech firms tend to have smaller real estate footprints and leaner workforces, they become…
CBRE examines hidden real estate considerations and cost factors that arise during mergers and acquisitions in the life sciences sector.
Capital Economics shares insights and outlook perspectives on alternative real estate assets drawn from client roundtable discussions.
Research examining how REITs invested in tech-related property sectors can reduce portfolio volatility and provide exposure to 21st century real estate.
CBRE examines the intersection of high-performance computing, life sciences research, and artificial intelligence as drivers of real estate demand and innovation infrastructure.
Knight Frank examines biotech growth and UK property demand, urging investors to focus on knowledge-dense clusters (Cambridge, Oxford, London) and flexible, future-proofed facilities.
Barings discusses emerging demand drivers and underwriting approaches for alternative real estate sectors and the case for diversification beyond the core property types.